Follow
Ruud Verrijk
Ruud Verrijk
Empirilogic, Delpharm Development Leiden, The Netherlands
Verified email at empirilogic.nl
Title
Cited by
Cited by
Year
Shifting paradigms: biopharmaceuticals versus low molecular weight drugs
DJA Crommelin, G Storm, R Verrijk, L de Leede, W Jiskoot, WE Hennink
International journal of pharmaceutics 266 (1-2), 3-16, 2003
2922003
Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application
MJ Nell, GS Tjabringa, AR Wafelman, R Verrijk, PS Hiemstra, JW Drijfhout, ...
Peptides 27 (4), 649-660, 2006
2042006
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes
JH Van Steenis, EM Van Maarseveen, FJ Verbaan, R Verrijk, ...
Journal of controlled release 87 (1-3), 167-176, 2003
1512003
Novel Controlled-Release Lemna-Derived IFN-α2b (Locteron): Pharmacokinetics, Pharmacodynamics, and Tolerability in a Phase I Clinical Trial
LGJ De Leede, JE Humphries, AC Bechet, EJ Van Hoogdalem, R Verrijk, ...
Journal of Interferon & Cytokine Research 28 (2), 113-122, 2008
1072008
The effect of formulation parameters on the size of poly ((2-dimethylamino) ethyl methacrylate)-plasmid complexes
JY Cherng, H Talsma, R Verrijk, DJA Crommelin, WE Hennink
European journal of pharmaceutics and biopharmaceutics 47 (3), 215-224, 1999
831999
The effect of core composition in biodegradable oligomeric micelles as taxane formulations
MG Carstens, PH de Jong, CF van Nostrum, J Kemmink, R Verrijk, ...
European journal of pharmaceutics and biopharmaceutics 68 (3), 596-606, 2008
792008
Reduction of systemic exposure and toxicity of cisplatin by encapsulation in poly-lactide-co-glycolide
R Verrijk, IJH Smolders, N Bosnie, AC Begg
Cancer research 52 (23), 6653-6656, 1992
661992
Single ocular injection of a sustained-release anti-VEGF delivers 6 months pharmacokinetics and efficacy in a primate laser CNV model
P Adamson, T Wilde, E Dobrzynski, C Sychterz, R Polsky, E Kurali, ...
Journal of Controlled Release 244, 1-13, 2016
592016
A mechanistic Study on the Chemical and Enzymatic Degradation of PEG‐Oligo (ε‐caprolactone) Micelles
MG Carstens, CF van Nostrum, R Verrijk, LGJ De Leede, DJA Crommelin, ...
Journal of pharmaceutical sciences 97 (1), 506-518, 2008
582008
Preclinical and Clinical In Vitro In Vivo Correlation of an hGH Dextran Microsphere Formulation
KDF Vlugt-Wensink, R De Vrueh, MG Gresnigt, CM Hoogerbrugge, ...
Pharmaceutical research 24 (12), 2239-2248, 2007
532007
Small Oligomeric Micelles Based on End Group Modified mPEG− Oligocaprolactone with Monodisperse Hydrophobic Blocks
MG Carstens, JJL Bevernage, CF van Nostrum, MJ van Steenbergen, ...
Macromolecules 40 (1), 116-122, 2007
472007
Modeling the release of proteins from degrading crosslinked dextran microspheres using kinetic Monte Carlo simulations
KDF Vlugt-Wensink, TJH Vlugt, W Jiskoot, DJA Crommelin, R Verrijk, ...
Journal of controlled release 111 (1-2), 117-127, 2006
432006
Polymer-coated albumin microspheres as carriers for intravascular tumour targeting of cisplatin
R Verrijk, IJH Smolders, JG McVie, AC Begg
Cancer chemotherapy and pharmacology 29 (2), 117-121, 1991
391991
Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors
V Gregoire, AC Begg, R Huiskamp, R Verrijk, H Bartelink
Radiotherapy and Oncology 27 (1), 46-54, 1993
361993
In vitro degradation behavior of microspheres based on cross-linked dextran
KDF Vlugt-Wensink, X Jiang, G Schotman, G Kruijtzer, A Vredenberg, ...
Biomacromolecules 7 (11), 2983-2990, 2006
342006
Preparation and characterization of albumin-heparin microspheres
HFM Cremers, G Kwon, YH Bae, SW Kim, R Verrijk, H Noteborn, J Feijen
Biomaterials 15 (1), 38-48, 1994
311994
Ototopical drops containing a novel antibacterial synthetic peptide: Safety and efficacy in adults with chronic suppurative otitis media
NFAW Peek, MJ Nell, R Brand, T Jansen-Werkhoven, EJ van Hoogdalem, ...
PloS one 15 (4), e0231573, 2020
292020
Hydrogels for the controlled release of pharmaceutical proteins
EPO Erythropoietin
Pharmaceutical technology, 2001
282001
Poly (ethylene glycol)− oligolactates with monodisperse hydrophobic blocks: Preparation, characterization, and behavior in water
MG Carstens, CF van Nostrum, A Ramzi, JD Meeldijk, R Verrijk, ...
Langmuir 21 (24), 11446-11454, 2005
232005
A comprehensive PC-based computer model for microdosimetry of BNCT
R Verrijk, R Huiskamp, AC Begg, FJ Wheeler, PRD Watkins
International journal of radiation biology 65 (2), 241-253, 1994
181994
The system can't perform the operation now. Try again later.
Articles 1–20